chr3-184135233-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The ENST00000491144.5(EIF2B5):n.196T>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000208 in 1,154,560 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00095 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000096 ( 1 hom. )
Consequence
EIF2B5
ENST00000491144.5 non_coding_transcript_exon
ENST00000491144.5 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.86
Genes affected
EIF2B5 (HGNC:3261): (eukaryotic translation initiation factor 2B subunit epsilon) This gene encodes one of five subunits of eukaryotic translation initiation factor 2B (EIF2B), a GTP exchange factor for eukaryotic initiation factor 2 and an essential regulator for protein synthesis. Mutations in this gene and the genes encoding other EIF2B subunits have been associated with leukoencephalopathy with vanishing white matter. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000945 (144/152324) while in subpopulation AFR AF= 0.00339 (141/41584). AF 95% confidence interval is 0.00293. There are 0 homozygotes in gnomad4. There are 70 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EIF2B5-DT | NR_183718.1 | n.29A>C | non_coding_transcript_exon_variant | 1/3 | ||||
EIF2B5-DT | NR_183719.1 | n.29A>C | non_coding_transcript_exon_variant | 1/4 | ||||
EIF2B5-DT | NR_183720.1 | n.29A>C | non_coding_transcript_exon_variant | 1/3 | ||||
EIF2B5-DT | NR_183721.1 | n.29A>C | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000946 AC: 144AN: 152206Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
144
AN:
152206
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000958 AC: 96AN: 1002236Hom.: 1 Cov.: 13 AF XY: 0.0000755 AC XY: 38AN XY: 503644
GnomAD4 exome
AF:
AC:
96
AN:
1002236
Hom.:
Cov.:
13
AF XY:
AC XY:
38
AN XY:
503644
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000945 AC: 144AN: 152324Hom.: 0 Cov.: 33 AF XY: 0.000940 AC XY: 70AN XY: 74482
GnomAD4 genome
AF:
AC:
144
AN:
152324
Hom.:
Cov.:
33
AF XY:
AC XY:
70
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Vanishing white matter disease Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at